Sienna Biopharmaceuticals’ struggles doomed company

You are here: Home > Biotech > Current Article

Sienna Biopharmaceuticals’ struggles doomed company

By Marissa Nall / Friday, December 20th, 2019 / Comments Off on Sienna Biopharmaceuticals’ struggles doomed company

The ranks of tri-county public companies thinned in December, with the exit of Sienna Biopharmaceuticals after a disappointing auction of its assets that garnered only $1.7 million for a firm that has raised hundreds of millions of dollars for dermatology drug research and development. The closure comes just as the Westlake Village company applied for…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.